资讯
3 小时之前
Immuneering Presents Additional Data Demonstrating Atebimetinib’s Broad Potential as a Backbone for Combination Therapy in Pancreatic Cancer
临床结果AACR会议
3 小时之前
Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
临床结果AACR会议
3 小时之前
Telomir Pharmaceuticals Selects Linical to Advance FDA-Cleared Phase 1/2 Clinical Trial of Telomir-Zn in Triple-Negative Breast Cancer
临床申请临床研究引进/卖出
3 小时之前
Visara Announces First Patient Dosed in ASCEND Phase 2b Trial of VIS-101 in Wet AMD
临床结果
3 小时之前
Providence Therapeutics Enrolls First Patient in World’s First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer
疫苗信使RNA临床研究免疫疗法
2026-11-19
引进/卖出
2026-11-19
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
临床结果上市批准
2026-11-19
并购
2026-11-19
NeuroGenesis Bio Receives FDA Clearance to Proceed with Expanded Access Program for NG01 in Progressive Multiple Sclerosis
细胞疗法临床结果
2026-11-18
Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep
临床结果